Health System Savings

The Value of MedTech To Treat AFib

Millions of Americans Suffer from AFib

Atrial fibrillation (also called AFib or AF) is the most common type of irregular heartbeat, or arrhythmia.1 A normal heart beats 60-100 times per minute. During an AFib episode, a person’s heart can beat 175 times or more per minute.2  
Often undiagnosed, AFib prevalence estimates vary between 2.7 million and 6.1 million Americans affected.3 Age is a major risk factor for AFib – at age 60, 1 in 25 Americans has AFib. This number increases to 1 in 10 at age 80.4  

When Dr. Martin Malawer started practicing in the 1970s, amputation was the standard treatment for young children and adolescents with bone and tissue cancer. Working with pioneers in the field of orthopedic oncology, Dr. Malawer helped to develop the first set of orthopedic endoprostheses, which included artificial bone and joint replacements. 

Use of diagnostic & therapeutic technologies (angioplasty, pacemakers, electrocardiograms, left ventricular ultrasound, chest x-rays) for treatment of people with heart disease generates net cost savings.